{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:55:40Z","timestamp":1782226540042,"version":"3.54.5"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CHENG-HSING Medical Foundation of National Cheng Kung University Hospital","award":["CHENG-HSING Medical Foundation of National Cheng Kung University Hospital"],"award-info":[{"award-number":["CHENG-HSING Medical Foundation of National Cheng Kung University Hospital"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206947","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T18:42:13Z","timestamp":1541616133000},"page":"e0206947","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9331-9018","authenticated-orcid":true,"given":"Pin-Nan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chih","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Cheng","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Chuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression","volume":"48","author":"HH Thein","year":"2008","journal-title":"Hepatology"},{"issue":"Suppl","key":"ref2","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"RH Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C","volume":"349","author":"T Poynard","year":"1997","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"F Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1097\/MD.0000000000000690","article-title":"Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan","volume":"94","author":"ML Yu","year":"2015","journal-title":"Medicine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/apt.14204","article-title":"Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-na\u00efve, genotype 1 hepatitis C infected patients","volume":"46","author":"MP Curry","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref7","article-title":"Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials","author":"EJ Gane","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/hep.24370","article-title":"A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C","volume":"54","author":"JL Dienstag","year":"2011","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/hep.23315","article-title":"Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial","volume":"51","author":"JE Everhart","year":"2010","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.21176","article-title":"The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients","volume":"43","author":"A Sangiovanni","year":"2006","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jhep.2016.01.034","article-title":"Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population","volume":"64","author":"S. Bruno","year":"2016","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"A.J. van der Meer","year":"2012","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"A Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"L Cast\u00e9ra","year":"2005","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0929-6646(09)60231-X","article-title":"Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants","volume":"106","author":"CH Chen","year":"2007","journal-title":"J Formos Med Assoc"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1607-551X(10)70073-5","article-title":"Viral hepatitis infections in southern Taiwan: a multicenter community-based study","volume":"26","author":"JF Yang","year":"2010","journal-title":"Kaohsiung J Med Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","article-title":"The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation","volume":"102","author":"M Hamaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13089-015-0030-8","article-title":"Point-of-care ultrasonography improves the diagnosis of splenomegaly in hospitalized patients","volume":"7","author":"AP Olson","year":"2015","journal-title":"Crit Ultrasound J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e3193","DOI":"10.1097\/MD.0000000000003193","article-title":"The application of liver stiffness measurement in residents without overt liver diseases through a community-based screening program","volume":"95","author":"PN Cheng","year":"2016","journal-title":"Medicine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.22007","article-title":"Acute viral hepatitis increases liver stiffness values measured by transient elastography","volume":"47","author":"U Arena","year":"2007","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.22056","article-title":"Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage","volume":"47","author":"A Sagir","year":"2008","journal-title":"Hepatology"},{"key":"ref23","article-title":"NASH Clinical Research Network. Vibration-controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease","author":"MS Siddiqui","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/apt.14529","article-title":"Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement","volume":"47","author":"T Karlas","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"ref25","article-title":"Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C","volume":"28","author":"S Bloom","year":"2018","journal-title":"J Hepatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/j.1572-0241.2002.05995.x","article-title":"Contribution of obesity to hepatitis C-related fibrosis progression","volume":"97","author":"V Ortiz","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","article-title":"Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity","volume":"33","author":"LE Adinolfi","year":"2001","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Y Shintani","year":"2004","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/hep.26437","article-title":"Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial","volume":"58","author":"Z Younossi","year":"2013","journal-title":"Hepatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T08:19:30Z","timestamp":1589012370000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206947"}},"subtitle":[],"editor":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206947","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,7]]}}}